文献速递肿瘤 PET/CT

成纤维细胞活化蛋白靶向显像在恶性间皮瘤中优于18F-FDG PET/CT:一项前瞻性、单中心、观察性试验

Fibroblast Activation Protein-Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial.
PubMed 文献 · J Nucl Med · 2024-08-01

在43例疑似或确诊恶性间皮瘤患者中,41例纳入68Ga-FAPI46 PET观察性试验分析,所有患者均接受68Ga-FAPI46 PET/CT、增强CT和18F-FDG PET/CT。主要终点达标:68Ga-FAPI46 SUVmax和SUVpeak与组织病理学FAP表达显著相关。68Ga-FAPI46与18F-FDG的敏感性相似,但68Ga-FAPI46的特异性和阳性预测值更高。

要点

  • 68Ga-FAPI46摄取强度与组织病理学FAP表达显著相关(SUVmax r=0.49,P=0.037;SUVpeak r=0.51,P=0.030)。
  • 基于组织病理学验证,68Ga-FAPI46与18F-FDG的敏感性相似:按患者分析为100.0% vs 97.3%,按区域分析为98.0% vs 95.9%。
  • 按区域分析,68Ga-FAPI46较18F-FDG具有更高的特异性(81.1% vs 36.8%)和阳性预测值(87.5% vs 66.2%)。

核心结论

  • 研究证实间皮瘤患者中68Ga-FAPI46摄取与组织病理学FAP表达存在关联,且68Ga-FAPI46较18F-FDG具有高敏感性和更高的特异性及阳性预测值。

研究设计与样本

  • 前瞻性、单中心、观察性试验(NCT04571086),43例疑似或确诊恶性间皮瘤患者中41例纳入68Ga-FAPI46 PET数据分析。
  • 所有患者均接受68Ga-FAPI46 PET/CT、增强CT和18F-FDG PET/CT,数据集由2名设盲读者解读。

主要发现

  • 主要终点达标:68Ga-FAPI46 SUVmax与组织病理学FAP表达显著相关(r=0.49,P=0.037),SUVpeak亦显著相关(r=0.51,P=0.030)。
  • 基于组织病理学验证,68Ga-FAPI46与18F-FDG的敏感性相似:按患者分析为100.0% vs 97.3%,按区域分析为98.0% vs 95.9%。
  • 按区域分析,68Ga-FAPI46较18F-FDG具有更高的特异性(81.1% vs 36.8%)和阳性预测值(87.5% vs 66.2%)。

关键数值与推荐

  • 主要终点为68Ga-FAPI46 PET摄取强度与组织病理学FAP表达的关联。
  • 次要终点为与18F-FDG PET/CT相比的检出率、敏感性、特异性、阳性预测值和阴性预测值。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The fibroblast activation protein (FAP) is highly expressed in tumor and stromal cells of mesothelioma and thus is an interesting imaging and therapeutic target. Previous data on PET imaging with radiolabeled FAP inhibitors (FAPIs) suggest high potential for superior tumor detection. Here, we report the data of a large malignant pleural mesothelioma cohort within a 68Ga-FAPI46 PET observational trial (NCT04571086). Methods: Of 43 eligible patients with suspected or proven malignant mesothelioma, 41 could be included in the data analysis of the 68Ga-FAPI46 PET observational trial. All patients underwent 68Ga-FAPI46 PET/CT, contrast-enhanced CT, and 18F-FDG PET/CT. The primary study endpoint was the association of 68Ga-FAPI46 PET uptake intensity and histopathologic FAP expression. Furthermore, secondary endpoints were detection rate and sensitivity, specificity, and positive and negative predictive values as compared with 18F-FDG PET/CT. Datasets were interpreted by 2 masked readers. Results: The primary endpoint was met, and the association between 68Ga-FAPI46 SUVmax or SUVpeak and histopathologic FAP expression was significant (SUVmax: r = 0.49, P = 0.037; SUVpeak: r = 0.51, P = 0.030).68Ga-FAPI46 and 18F-FDG showed similar sensitivity by histopathologic validation on a per-patient (100.0% vs. 97.3%) and per region (98.0% vs. 95.9%) basis. Per-region analysis revealed higher 68Ga-FAPI46 than 18F-FDG specificity (81.1% vs. 36.8%) and positive predictive value (87.5% vs. 66.2%). Conclusion: We confirm an association of 68Ga-FAPI46 uptake and histopathologic FAP expression in mesothelioma patients. Additionally, we report high sensitivity and superior specificity and positive predictive value for 68Ga-FAPI46 versus 18F-FDG.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Kessler L, Schwaning F, Metzenmacher M, et al. Fibroblast Activation Protein-Directed Imaging Outperforms 18F-FDG PET/CT in Malignant Mesothelioma: A Prospective, Single-Center, Observational Trial. J Nucl Med. 2024. PMID: 38960716. doi:10.2967/jnumed.124.267473

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。